Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (4990)	1/10/2004 5:31:33 PM
From: Frank_Ching	Read Replies (1) \| Respond to of 5582

Looks like the Zicam is about ready to hit the fan according to this lawyers conference. mealeys.com

To: DanZ who wrote (4990)	1/28/2004 6:47:48 PM
From: StockDung	Respond to of 5582

Burn baby burn! - Disco inferno! Burn baby burn! - Burn that mother down, yoh! Burn baby burn! - Disco inferno! Burn baby burn! - Burn that mother down Burnin'! Up above my head I hear music in the air - I hear music! That makes me know there's (somebody) a promise somewhere Satisfaction came in a chain reaction - Do you hear? I couldn't get enough, so I had to self destruct, The heat was on, rising to the top Everybody's goin' strong That is when my spark got hot I heard somebody say Burn baby burn! - Disco inferno! (Aah yeah!) Burn baby burn! - Burn that mother down Burn baby burn! - Disco inferno!, yeah! Burn baby burn! - Burn that mother down x2 Burnin’!

To: DanZ who wrote (4990)	1/29/2004 9:39:44 PM
From: StockDung	Respond to of 5582

HEY MATRIXX, IS THIS YOU? superiorcourt.maricopa.gov

To: DanZ who wrote (4990)	1/30/2004 10:10:45 AM
From: StockDung	Respond to of 5582

Trouble Right Here in River City Oh, ya got trouble! Ya got lots & lots 'a trouble! That game with the 15 numbered balls is the devil's tool! (devil's tool!) Oh yes, we've got trouble, trouble! (Oh yes, we've got trouble here, we've got big, big trouble) With a "T"! (with a capital T!) That rhymes with P! (that rhymes with P) That stands for pool! (that stands for pool!)

To: DanZ who wrote (4990)	1/30/2004 10:19:47 AM
From: StockDung	Respond to of 5582

THE BAZAAR STORY OF YAHOO POSTER PEDROCPAGUY Re: Is it Safe when Doctors say this? by: pedrocpaguy 01/30/04 10:02 am Msg: 86879 of 86880 Have any of you noted that the two most recent anti-Zicam participants ("painful" and "wink") have only been on board here at Yahoo for very short times. Painful signed on 1/28/04 and Wink got his privileges on 12/16/03, and neither of them posted here before this week. Both of them write with a good level of articulation (as opposed to Floyd & Co.), a trait common to lawyers, "expert" witness doctors, and/or hired guns who may be from competitors that are losing market share to Zicam. Now, whether they are lawyers, potential "expert" witnesses, hired guns or whatever is obviously conjectural on my part. But it is something to be considered. Those of you who are taking exception to the taunts of these two might like to consider that you may also be giving the tort bar and their lackeys a road map to the defense's strategy and tactics. So, given that possibility, why help them? I also find it interesting that they elicited from one of you what your professional background is all about, and that guy stepped up and told them what they wanted to know. Their's is a tactic common to lawyers, my friends. Which is: Find out the qualifications of the enemy, learn from it and then use it against him. Beware what you say and to whom you say it. To prove my point, I draw upon what General Patton said after he kicked Rommell's ass in North Africa. "I read your book, you bastard." Carry on, men. Posted as a reply to: Msg 86871 by wink_martiendale finance.messages.yahoo.com

To: DanZ who wrote (4990)	1/31/2004 5:02:01 PM
From: StockDung	Respond to of 5582

=DJ : FDA Looks Into Complaints About Zicam By Carol S. Remond A Dow Jones Newswires Column NEW YORK (Dow Jones)--The Food and Drug Administration is looking into complaints that an over-the-counter common-cold medicine manufactured by a unit of Matrixx Initiatives Inc. (MTXX) may be causing some users to lose their sense of smell. The FDA's interest follows at least three lawsuits filed by individuals against Matrixx and Zicam LLC, a wholly-owned subsidiary, by users of Zicam Cold Remedy, a nasal spray designed to deliver a zinc gel into the nasal opening. A spokesman for Matrixx declined to comment on the lawsuits. Matrixx has not disclosed the lawsuits or that the FDA is looking into complaints that users of Zicam Cold Remedy lost their sense of smell, a condition called anosmia. None of the lawsuits specify damages being sought. A spokeswoman for the FDA said the agency "is aware of problems (that) people are reporting" and is investigating the complaints. The FDA spokeswoman would not say how many complaints were received. The spokeswoman said generally any investigation like this would involve contacting the complainants and the company manufacturing the product. Matrixx Chief Financial Officer William Hemelt said that Zicam Cold Remedy, one of 10 Zicam products, accounted for about 60% of Matrixx' revenues last year. Hemelt declined to comment on the lawsuits and said that the company's policy is to disclose lawsuits that "are considered material to the company or outside ordinary course of business." Hemelt also declined to comment on the fact that the FDA is looking into complaints relating to one of the company's products. "Our policy is not to comment on any discussion or communication with any regulatory authorities," Hemelt said. Matrixx' filings with the Securities and Exchange Commission show that Zicam products "are subject to regulation by the FDA, including regulations with respect to labeling of products, approval of ingredients in products, claims made regarding the products, and disclosure of product ingredients." According to some studies, the intake of zinc, either orally or through the nasal passage, may help combat cold symptoms. However, other studies, conducted on animals, have found that high concentration of Zinc injected through the nose may cause anosmia. In information provided to Dow Jones, Matrixx acknowledges that some studies have "attempted to link nasal products containing Zinc to the onset of anosmia." But the company argues that this research is based on products containing zinc sulfate, and not zinc gluconate, the solution contained in Zicam Cold Remedy. Matrixx argues that "zinc gluconate has properties that are significantly different from those of zinc sulfate." Some medical experts seem to disagree with Matrixx' views, however. Robert Henkin of the Taste and Smell Clinic in Washington, D.C., says that there is not much difference between the two zinc compounds. According to Henkin, when it comes to the injection of zinc through the nose, it's not about compound but rather about concentration. "When delivered in a spray, it's possible to have a high enough concentration of zinc to injure the olfactory epithelium," Henkin said. Henkin cautioned that high concentration of zinc injected through the nose is only one of the many reasons why cold sufferers may lose their sense of smell. "It's clear that it could be related, but there could be other things as well, including the viral infection itself." In a presentation to the American Rhinologic Society last September in Orlando, Dr. Bruce Jafek, Dr. Miriam Linschoten and Dr. Bruce Murrow from the Department of Otolaryngology at the University of Colorado School of Medicine, cautioned against the use of zinc spray. "Zinc ions remain toxic to human olfactory epithelium and continued reports of total, probably irreversible, anosmia, can be expected as long as intranasal zinc gluconate gel (Zicam) continues to be used," according to a summary of the presentation included in a program for the conference. Jafek wasn't available for comment. The first suit against Matrixx was filed last October in the U.S. District Court, Western District of Michigan. In that complaint, Dennis Christensen says that he felt an immediate and intense "stinging and/or burning sensation in his nose" after using Zicam Cold Remedy. "Since this one and only use of Zicam Cold Remedy Nasal Spray, plaintiff Dennis Christensen has totally lost his sense of smell," according to the complaint. In its answer filed Jan. 9, Matrixx said it lacked sufficient information to answer the complaint. Matrixx said Zicam is a drug that has met all of the FDA's "requirements to lawfully market an over the counter homeopathic drug in interstate commerce in the U.S." A second lawsuit was filed in the Circuit Court of Etowah County in Alabama on Dec. 18. That suit filed by Janie Sutherland also names Wal-Mart Stores Inc. (WMT) as a defendant. In an answer filed on Jan. 22, Matrixx denied allegations made in the complaint. Wal-Mart also denied the charges. A spokeswoman for Wal-Mart declined to comment about the lawsuit. A third lawsuit was filed last week in the Superior Court of the State of Arizona in Maricopa County. In that suit, three plaintiffs allege that they lost their sense of smell and taste immediately after using Zicam Cold Remedy. Matrixx' CFO Hemelt declined to comment on whether a recent drop in the price of the company's shares was related to the lawsuits. Matrixx' stock reached a 52-week high of $20.89 a share on Jan. 8, a day after the company said it expected total revenues for its fiscal year 2003 to grow 80% compared to 2002. Matrixx said it expected fully diluted earnings per share to be between 33 cents and 38 cents. Matrixx's stock closed at $13.55 a share Friday, down a penny. (Carol S. Remond is one of four "In The Money" columnists who take a sophisticated look at the value of companies and their securities and explore unique trading strategies.) -By Carol S. Remond; Dow Jones Newswires; 201 938 2074; carol.remond@dowjones.com (END) Dow Jones Newswires January 30, 2004 17:01 ET (22:01 GMT)

To: DanZ who wrote (4990)	1/31/2004 7:02:03 PM
From: StockDung	Respond to of 5582

Try zinc-free FDA approved Afrin!

To: DanZ who wrote (4990)	5/13/2004 12:28:11 PM
From: StockDung	Respond to of 5582

LITTLE SECRETS TRICKLE OUT ABOUT DR YUI, WHO SPOKE OUT ABOUT TURNERS STUDY ON ZICAM. SEEMS HE FORGOT TO TELL TURNER THAT HE WORKED FOR R. STEVEN DAVIDSON AT GLOBAL CLINICALS web.archive.org Welcome to GCI's Scientific Advisory Board Scientific advisory board consist of some of the finest PhDs and MDs in the country. Sam Yiu, M.D., Ph.D. Farshid Sam Rahbar, M.D., F.A.C.P. Sion Nobel, M.D. Ernesto Barron, B.S. ================================================== Ineffectiveness of Intranasal Zinc Gluconate for Prevention of Experimental Rhinovirus Colds Ronald B. Turner journals.uchicago.edu ============================================================= Evaluation of the Efficacy of Intranasal Zinc Gluconate Samuel C. Yiu journals.uchicago.edu =================================================== Reply by Ronald B. Turner to Dr. Yiu journals.uchicago.edu ======================================== CHIEF EXECUTIVE: R STEVEN DAVIDSON, PRESIDENT DUNS COMPANY NAME: BIOTEM CYTOTECHNOLOGIES, D.B.A. GLOBAL CLINICAL INC ==================================================== BIOTEM CYTOTECHNOLOGIES February 13, 2004 *THIS DATA IS FOR INFORMATIONAL PURPOSES ONLY* Copyright 2004 Dun & Bradstreet, Inc. Federal Employer Identification Numbers BIOTEM CYTOTECHNOLOGIES 6430 VARIEL AVE STE 102 WOODLAND HLS, CA 91367 TELEPHONE: 818-340-8923 February 13, 2004 LENGTH: 43 words FEIN: 95-465-3174 CHIEF EXECUTIVE: R STEVEN DAVIDSON, PRESIDENT DUNS COMPANY NAME: BIOTEM CYTOTECHNOLOGIES, D.B.A. GLOBAL CLINICAL INC SIC: 87339904 DUNS SOURCE: UNITED STATES DEPT TREASURY - IRS - NON-PROFIT LANGUAGE: ENGLISH

To: DanZ who wrote (4990)	5/27/2004 5:13:43 PM
From: StockDung	Respond to of 5582

=DJ "Mob On Wall Street" Defendants Sentenced In Florida By Carol S. Remond Of Dow Jones Newswires NEW YORK (Dow Jones)--Defendants in the "Mob On Wall Street" case were sentenced Wednesday, four years after they were charged in a 21-count federal indictment in the U.S. District Court for the Middle District of Florida. Philip Abramo, Philip Gurian, Glen Vittor, Louis Consalvo and Barry Gesser were charged in June 1999 with mail fraud, wire fraud, securities fraud, interference with commerce by extortion, conspiracy to commit money laundering and witness tampering. The federal government alleged that Abramo, a captain in the Decavalcante organized crime family, and the other defendants used two now-shuttered brokerage firms called Sovereign Equity Management Corp. and Falcon Trading Group to reap huge profits after reselling, in the U.S., shares of several small companies obtained at a discount by several mob-controlled firms in the Bahamas. Abramo and his brother-in-law Consalvo were separately indicted in 2000 in New York on charges including securities fraud and murder. Gurian, Vittor, Consalvo and Gesser had each pleaded to one count of conspiracy to commit mail fraud, wire fraud and securities fraud and one count of mail fraud. Abramo had pleaded one count of conspiracy to commit mail fraud, wire fraud and securities fraud and two counts of mail fraud. Abramo and Consalvo had tried unsuccessfully to withdraw their guilty pleas in Florida after they were charged in New York. Abramo received a 70-month jail sentence and forfeited $1.1 million previously seized by the government in the Bahamas. Consalvo received a 27-month jail sentence. Gurian, who served six months in jail in the U.S. and Switzerland when he was arrested after fleeing the U.S., was sentenced to time served and a three-year probation period. Gurian forfeited $7.5 million when he became a government witness in early 2000. According to a lawyer present at the sentencing, the government said Gurian was an extraordinary informant that testified for the government in several jurisdictions including the Eastern District of New York, the Southern District of New York, the Southern District court of Florida and the Middle District Court of Florida and a California district court. Vittor and Gesser never served time. They were both sentenced to a three-year probation period. Gesser forfeited $2.1 million and Vittor gave up $3.1 million. The federal government had filed court documents recommending reduction of sentences for Consalvo, Gurian, Vittor and Gesser in recognition of the defendants' "substantial assistance". Abramo and Consalvo have yet to be sentenced in New York. Abramo was found guilty by a Manhattan Federal Court jury of a racketeering conspiracy including murder, extortion and stock fraud. He has yet to be sentenced in that case. Joel Winograd, a lawyer for Consalvo, said that his client was in the process of working out an agreement with the government and that his Florida and New York sentences would be served concurrently. Gurian's 2000 guilty plea agreement shows that he admitted to defrauding "the investing public in general and the retail customers of Sovereign in particular through the sale of stock at artificially inflated prices in conjunction with Falcon Trading Group, a Gurian controlled company." An "In The Money" column last year highlighted Gurian's connections to two investors in a development company called HiEnergy Technologies Inc. (HIET). The Securities and Exchange commission launched an investigation into HiEnergy shortly afterwards. The SEC said in court documents that Gurian's mother and her boyfriend owned 80% of HiEnergy's shares in 2002. Court documents filed by the SEC in the U.S. District Court for the Southern District of Florida show that the SEC is investigating a scheme through which Gurian "controlled or is controlling HiEnergy without disclosing his involvement to the Commission or HiEnergy investors." -By Carol S. Remond; Dow Jones Newswires; 201 938 2074; carol.remond@dowjones.com (END) Dow Jones Newswires